Unigen Pharmaceuticals Expands Sales of its Proprietary Ingredients in Europe and Brazil

Broomfield, CO – June 12, 2003 – Unigen Pharmaceuticals, Inc., a leading research and development facility and supplier of proprietary plant-derived biologically active ingredients to the natural products and pharmaceutical industries, has expanded its sales presence in Europe and Latin America by signing agency and distribution agreements with six international corporate partners.

Unigen’s European partners include Lake Chemical in the United Kingdom; CH Erbshloh in Germany, Poland, Austria and Switzerland; Bionord in Denmark, Sweden, Finland and Norway (for pharmaceutical and health food products); Pharmalogic in Denmark, Sweden, Finland, Norway, Italy, Greece and Poland (for specialty channels such as MLM’s, magazines, TV, etc.); Zeus Quimica in Spain and Portugal; and Will & Co in Belgium and the Netherlands. Some of these partners have a long and proven record representing Aloecorp, one of Unigen’s sister companies. In addition, Unigen has expanded into the Brazilian market with representation from Ayalla Marketing. All of these companies market to the pharmaceutical, nutraceutical and cosmeceutical industries.

“Many international companies are answering the call for finished products made with novel and efficacious active ingredients that are backed by sound science,” stated Derek Hall, Unigen’s President and CEO. “Our new international agencies are leaders in their fields, and are positioned to confidently represent Unigen’s proprietary ingredients in the countries they serve.”

Regan Miles, Unigen’s Vice President, Sales and Marketing, said, “I believe our international team of distributors has a proven track record for technical and specialty sales in these markets and are poised to launch the Unigen products throughout those nations.”

Unigen is expected to finalize another agreement by the end of this month for distributor representation in France.

# # #

About Unigen Pharmaceuticals
Unigen Pharmaceuticals, Inc. is a leading natural products research and development company and proprietary ingredients supplier. The company is dedicated to the discovery of botanically derived therapeutic compounds that address consumer health needs and help improve the quality of human life. Unigen (www.unigenpharma.com), and sister company Aloecorp, are subsidiaries of Univera, Inc. Both companies focus on identifying and studying the unique ingredients of medicinal botanicals (Aloecorp’s focus is on Aloe vera) and then formulating proprietary raw materials for use in cosmeceutical, nutraceutical and pharmaceutical products.

Regan Miles, V.P. – Sales & Marketing
Unigen Pharmaceuticals, Inc.
303-438-8666 x11
[email protected]

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.